27:
157:
In 2015, ESMO published the first version of its
Magnitude of Clinical Benefit Scale to grade the magnitude of clinical benefit of cancer therapies incorporating efficacy, long-term survival and side-effects of any anticancer agent into a single score. ESMO-MCBS was updated with the publication of
148:
ESMO publishes handbooks, scientific meeting reports, and medical oncology training guidelines. The
Society provides fellowships for research training for young oncologists, an Exam in Medical Oncology and an accreditation program for institutes providing patients with integrated supportive and
131:. Each Clinical Practice Guideline includes information on the incidence of the malignancy, diagnostic criteria, staging of disease and risk assessment, treatment plans and follow-up designed to help oncologists deliver an appropriate quality of care to their patients.
139:
The annual ESMO Congress is attended by 30,000 participants. The congress presents the latest scientific developments in basic, translational and clinical cancer research and contextualises new findings for practical implementation in every day patient care.
191:"A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)"
303:
127:
The ESMO Clinical
Practice Guidelines (CPG) are intended to provide oncology professionals with a set of recommendations for the best standards of cancer care, based on the findings of
99:) is a professional organisation for medical oncology. With more than 40,000 members representing oncology professionals from over 177 countries worldwide, ESMO was founded in 1975.
115:, publishes articles addressing medical oncology, surgery, radiotherapy, pediatric oncology, basic research and the comprehensive management of patients with malignant diseases.
298:
293:
149:
palliative care. Through an online professional networking platform ESMO members collaborate, interact and share knowledge on topics of research and clinical practice.
238:
Cherny, N. I.; Dafni, U.; Bogaerts, J.; Latino, N. J.; Pentheroudakis, G.; Douillard, J.-Y.; Tabernero, J.; Zielinski, C.; Piccart, M. J. (2017-10-01).
159:
189:
Cherny, N. I.; Sullivan, R.; Dafni, U.; Kerst, J. M.; Sobrero, A.; Zielinski, C.; de Vries, E. G. E.; Piccart, M. J. (August 2015).
128:
119:
is the official journal of ESMO and from 2008 of the
Japanese Society for Medical Oncology (JSMO)
111:
269:
261:
220:
212:
251:
202:
63:
287:
153:
European
Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
158:
the version 1.1 in 2017. Forms are available from the official website of ESMO.
41:
176:
265:
216:
256:
239:
207:
190:
273:
224:
26:
37:
83:
240:"ESMO-Magnitude of Clinical Benefit Scale version 1.1"
109:
Founded in 1990, ESMO’s flagship scientific journal,
144:
Additional
Continuing Medical Educational Resources
79:
69:
57:
47:
33:
304:International organisations based in Switzerland
179:Organisation's website, accessed July 9th 2024
8:
19:
25:
18:
299:European medical and health organizations
294:Cancer organisations based in Switzerland
255:
206:
169:
93:European Society for Medical Oncology
20:European Society for Medical Oncology
7:
14:
123:ESMO Clinical Practice Guidelines
1:
320:
24:
16:Professional organisation
129:evidence-based medicine
257:10.1093/annonc/mdx310
208:10.1093/annonc/mdv249
21:
244:Annals of Oncology
195:Annals of Oncology
117:Annals of Oncology
112:Annals of Oncology
104:Annals of Oncology
59:Official language
250:(10): 2340–2366.
89:
88:
311:
278:
277:
259:
235:
229:
228:
210:
201:(8): 1547–1573.
186:
180:
174:
135:ESMO Conferences
29:
22:
319:
318:
314:
313:
312:
310:
309:
308:
284:
283:
282:
281:
237:
236:
232:
188:
187:
183:
175:
171:
166:
155:
146:
137:
125:
107:
72:
60:
50:
17:
12:
11:
5:
317:
315:
307:
306:
301:
296:
286:
285:
280:
279:
230:
181:
168:
167:
165:
162:
154:
151:
145:
142:
136:
133:
124:
121:
106:
101:
87:
86:
81:
77:
76:
73:
70:
67:
66:
61:
58:
55:
54:
51:
48:
45:
44:
35:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
316:
305:
302:
300:
297:
295:
292:
291:
289:
275:
271:
267:
263:
258:
253:
249:
245:
241:
234:
231:
226:
222:
218:
214:
209:
204:
200:
196:
192:
185:
182:
178:
173:
170:
163:
161:
160:
152:
150:
143:
141:
134:
132:
130:
122:
120:
118:
114:
113:
105:
102:
100:
98:
94:
85:
82:
78:
74:
68:
65:
62:
56:
52:
46:
43:
39:
36:
32:
28:
23:
247:
243:
233:
198:
194:
184:
177:ESMO Mission
172:
156:
147:
138:
126:
116:
110:
108:
103:
96:
92:
90:
49:Membership
34:Headquarters
42:Switzerland
288:Categories
164:References
266:0923-7534
217:0923-7534
274:28945867
225:26026162
84:esmo.org
80:Website
71:Staff
64:English
272:
264:
223:
215:
53:40,000
38:Lugano
270:PMID
262:ISSN
221:PMID
213:ISSN
97:ESMO
91:The
252:doi
203:doi
75:125
290::
268:.
260:.
248:28
246:.
242:.
219:.
211:.
199:26
197:.
193:.
40:,
276:.
254::
227:.
205::
95:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
